We hypothesized that alterations in the functional gradients of the medial parietal cortex would be more strongly associated with CSF AD biomarkers, ApoE ε4 allele carriership and memory compared to commonly used connectivity measures, providing support to the use of this novel imaging marker to detect early changes associated with the preclinical stage of AD. This evidence concerns the gene APOE and Alzheimer disease.